DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Ramagopal UA, Liu W, Garrett-Thomson SC. et al.
Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab.
Proc Natl Acad Sci U S A 2017;
114 (21) E4223-E4232
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.